Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.